Anticoagulants

"Anticoagulants" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Agents that prevent BLOOD CLOTTING.

Descriptor ID	D000925
MeSH Number(s)	D27.505.954.502.119
Concept/Terms	Anticoagulants Anticoagulants Anticoagulation Agents Agents, Anticoagulation Anticoagulant Agents Agents, Anticoagulant Anticoagulant Drugs Drugs, Anticoagulant Anticoagulant Indirect Thrombin Inhibitors Indirect Thrombin Inhibitors Inhibitors, Indirect Thrombin Thrombin Inhibitors, Indirect

Below are MeSH descriptors whose meaning is more general than "Anticoagulants".

Chemicals and Drugs [D]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Therapeutic Uses [D27.505.954]
Hematologic Agents [D27.505.954.502]
Anticoagulants [D27.505.954.502.119]

Below are MeSH descriptors whose meaning is related to "Anticoagulants".

Below are MeSH descriptors whose meaning is more specific than "Anticoagulants".

Anticoagulants
Antithrombins

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Anticoagulants" by people in this website by year, and whether "Anticoagulants" was a major or minor topic of these publications.

Bar chart showing 105 publications over 27 distinct years, with a maximum of 9 publications in 2020

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1997	0	1	1
1999	0	1	1
2001	0	1	1
2002	2	0	2
2003	2	2	4
2004	1	2	3
2005	1	0	1
2006	1	1	2
2007	1	0	1
2008	1	0	1
2009	4	2	6
2010	4	1	5
2011	2	1	3
2012	3	3	6
2013	4	2	6
2014	6	0	6
2015	5	1	6
2016	3	1	4
2017	4	0	4
2018	3	3	6
2019	2	5	7
2020	6	3	9
2021	2	4	6
2022	2	3	5
2023	0	5	5
2024	2	0	2
2025	2	0	2

Below are the most recent publications written about "Anticoagulants" by people in Profiles.

Omole TD, Mrkva A, Ferry D, Shepherd E, Caratelli J, Davis N, Akatue R, Bickmore T, Paasche-Orlow MK, Magnani JW. Augmenting Engagement in Decentralized Clinical Trials for Atrial Fibrillation: Development and Implementation of a Programmatic Architecture. JMIR Cardio. 2025 May 12; 9:e66436.

View in: PubMed
Warach SJ, Davis LA, Lawrence P, Gajewski B, Wick J, Shi F, Shang TT, Olson DM, Prasad S, Birnbaum L, Richardson JM, Savitz SI, Goldberg MP, Cruz-Flores S, Alba I, Anderson J, Kimmel B, Venkatasubba Rao CP, King B, Dula AN, Milling TJ. Optimal Delay Time to Initiate Anticoagulation After Ischemic Stroke in Atrial Fibrillation: A Pragmatic, Response-Adaptive Randomized Clinical Trial. JAMA Neurol. 2025 May 01; 82(5):470-476.

View in: PubMed
Albaeni A, Li S, Shan Y, Thakker R, Gaalema DE, Saxena R, Kuo YF, Jneid H, Goodwin J. Outcomes Associated With Novel Oral Anticoagulants and Warfarin in Patients With Cardiac Thrombus Following ST-Segment Elevation Myocardial Infarction. Am J Cardiol. 2025 Feb 01; 236:72-78.

View in: PubMed
Dumas A, Goyal N, Mottamal M, Afosah DK, Al-Horani RA. Discovery of a new lead molecule to develop a novel class of human factor XIIa inhibitors. J Thromb Thrombolysis. 2024 Dec; 57(8):1308-1314.

View in: PubMed
Rodr?guez-Fern?ndez K, Reynaldo-Fern?ndez G, Reyes-Gonz?lez S, de Las Barreras C, Rodr?guez-Vera L, Vlaar C, Monbaliu JM, Stelzer T, Duconge J, Mangas-Sanjuan V. New insights into the role of VKORC1 polymorphisms for optimal warfarin dose selection in Caribbean Hispanic patients through an external validation of a population PK/PD model. Biomed Pharmacother. 2024 Jan; 170:115977.

View in: PubMed
Sahl?n AO, Jiang H, Lau YH, Cuenza L, Cader FA, Al-Omary M, Surunchupakorn P, Ho KH, Sung J, Lee D, Honda S, Tan Wei Chieh J, Yap J. Direct Oral Anticoagulation Versus Warfarin in Left Ventricular Thrombus: Pooled Analysis of Randomized Controlled Trials. J Clin Pharmacol. 2023 10; 63(10):1101-1107.

View in: PubMed
Desai R, Mondal A, Prasad A, Vyas A, Jain A, Rupareliya C, Shah M, Paul T, Kumar G, Sachdeva R. Concurrent Cardio-Cerebral Infarctions in COVID-19: A Systematic Review of Published Case Reports/Series. Curr Probl Cardiol. 2023 Oct; 48(10):101814.

View in: PubMed
Lee HJ, Kim HK, Kim BS, Han KD, Park CS, Rhee TM, Park JB, Lee H, Kim YJ. Safety and effectiveness of anticoagulation with non-vitamin K antagonist oral anticoagulants and warfarin in patients on tuberculosis treatment. Sci Rep. 2023 02 04; 13(1):2060.

View in: PubMed
Al-Horani RA, Afosah DK, Mottamal M. Triazol-1-yl Benzamides Promote Anticoagulant Activity via Inhibition of Factor XIIa. Cardiovasc Hematol Agents Med Chem. 2023; 21(2):108-119.

View in: PubMed
Steiner HE, Carrion KC, Giles JB, Lima AR, Yee K, Sun X, Cavallari LH, Perera MA, Duconge J, Karnes JH. Local Ancestry-Informed Candidate Pathway Analysis of Warfarin Stable Dose in Latino Populations. Clin Pharmacol Ther. 2023 03; 113(3):680-691.

View in: PubMed

People

Explore

Similar Concepts

Top Journals